Commerzbank: Buyback Progress, Analyst Doubts, and Two November Tests

Commerzbank's weekly buyback confirms delivery, but Deutsche Bank and RBC downgrades leave the strategic debate open ahead of November tests.

Commerzbank's latest disclosure of share purchases keeps one part of its capital-return story on track, yet it does nothing to settle the debate over what comes next. The lender reported buying back 2,987,942 of its own shares during the preceding week, bringing the cumulative total under the current program to 11,114,083 shares as of the end of that period.

That steady execution matters, but it is not the same thing as a fresh strategic catalyst. When expected distributions are already reflected in the share price, an ongoing buyback confirms delivery rather than opening a new chapter. Deutsche Bank made precisely this point when it downgraded the stock to "Hold" from "Buy" on September 30, leaving its price target at EUR 42. The broker argued that stronger net interest income and capital distributions had largely already materialized or been priced in, and it flagged uncertainty about the bank's future strategy. According to a dpa-AFX report, the downgrade weighed on the shares at the time.

Two Brokers, Two Sets of Concerns

RBC then added its own note of caution. On October 2, the firm cut its target to EUR 40 from EUR 43 and lowered its rating to "Sector Perform" from "Outperform," citing higher cost of equity as well as added risk and reduced predictability stemming from UniCredit's plans. The two downgrades carry different emphases: Deutsche Bank focused on positive developments already in the price, while RBC pointed to a harder-to-model environment.

The distinction investors face is therefore between dependable execution and any additional upside surprise. A buyback announcement documents purchases of own stock; on its own, it answers neither the question of future earnings nor that of strategic direction.

An IKB Deal Reshapes the Competitive Map

Separately, Crédit Agricole's announced takeover of SME financier IKB has pushed competition in German mid-market lending into sharper focus. Media reports identified the deal as a trigger for the recent positive move in Commerzbank shares, putting a transaction outside the company at the center of trading. The announcement is not the same as a completed acquisition.

For shareholders, the significance lies mainly in potential competitive pressure: a change of ownership at IKB could intensify rivalry in Germany's mid-market business. No concrete earnings effect for Commerzbank, and no improvement in its business outlook, can be derived from that. The friendly market impulse and the economic consequences of the plan should be assessed separately. The stock gained 1.4% and closed at EUR 38.60, a same-day reaction showing the market took the sector news positively without settling its longer-term implications.

A Higher Target, Not an Upgrade

RBC raised its Commerzbank target to EUR 41 from EUR 40 while confirming its "Sector Perform" rating. The moderate increase was explicitly not an upgrade — a distinction that matters more than the higher number itself. The analyst move provides a limited positive valuation impulse but no shift toward a more optimistic recommendation, and investors should not read the target adjustment as a comprehensive re-rating. Together with the IKB announcement, it helps explain the friendlier market reaction without removing the possible competitive fallout.

Two Separate November Yardsticks

Meanwhile, UniCredit's takeover plan remains a valuation factor in its own right. On Friday, the European Commission set November 16 as its deadline for deciding on the requested antitrust review. UniCredit is the applicant; Commerzbank is the target. The deadline is not yet a decision on the proposal.

The next concrete tests thus sit on two different levels: Commerzbank's own business performance and the competition-law assessment of UniCredit's plans. The bank's next scheduled results and analyst event is November 5, when it will publish figures for the third quarter of 2026. Neither the positive sector impulse nor further buyback updates substitute for those earnings or for the regulatory ruling — and keeping that separation in view is what matters most for valuing the stock.